Sonix Health vs Tempus ECG-AF
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Sonix Health focuses on automating the analysis and reporting of echocardiography images to enhance diagnostic precision for various cardiac conditions. Tempus ECG-AF, conversely, utilizes AI to analyze 12-lead ECGs specifically to predict the risk of new-onset atrial fibrillation in older patients. While both are FDA-cleared cardiology AI tools, they address different diagnostic modalities and clinical questions, making them complementary rather than direct competitors.
Choose Sonix Health if…
Choose Sonix Health if your cardiology department or critical care unit seeks to significantly enhance the efficiency and precision of echocardiogram analysis. This tool is ideal for automating complex measurements, standardizing reporting, and improving diagnostic accuracy across a high volume of cardiac ultrasound images.
View Sonix Health →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your practice focuses on proactively identifying older patients (65+) at elevated risk for developing new-onset atrial fibrillation within the next year. This solution is best suited for integrating into existing ECG workflows to enable earlier intervention and personalized management strategies for this specific patient population.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Sonix Health | Tempus ECG-AF |
|---|---|---|
| Pricing | Contact vendor for pricing. | Contact vendor |
| Deployment | Software only, installed directly on customer PC hardware; also offers cloud or on-premise options. | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Sonix Health | Tempus ECG-AF |
|---|---|---|
| Name | Sonix Health | Tempus ECG-AF |
| Company | Ontact Health Co. | Tempus AI, Inc. |
| Description | FDA-cleared AI-powered echocardiography analysis solution that automates the measurement and reporting of cardiac ultrasound images, enhancing efficiency and diagnostic precision for physicians. | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Primary Function | Automated echocardiography analysis (measurement and reporting) | Identifies patients ≥65 at risk of developing Atrial Fibrillation/Flutter (AF) within 12 months from 12-lead ECGs |
| Key Features | AI-Powered Fully-Automated Echocardiography Analysis, View Recognition, Auto Measure, Auto Strain, Image Quality Meter, DICOM Compliant, Automated Report Generation, Vendor-independent technology | AI-based algorithm for 12-lead ECG analysis, Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months, Intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, Results interpreted in conjunction with other diagnostic information and clinical history, Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems, Trained on over 1.5 million ECGs from over 500,000 patients |
| Specialties | Cardiology, Critical Care, Radiology | Cardiology, Geriatrics, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Sonix Health and Tempus ECG-AF.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Sonix Health is an AI-powered solution designed to automate the measurement and reporting of cardiac ultrasound images, enhancing efficiency and diagnostic precision for physicians. Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Sonix Health analyzes cardiac ultrasound images. Tempus ECG-AF analyzes 12-lead ECG recordings.
Sonix Health is indicated for use in adult populations for quantifying and reporting echocardiography. Tempus ECG-AF is intended for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.
Sonix Health is a software-only solution that can be installed directly on customer PC hardware, with cloud or on-premise options, and is DICOM compliant and vendor-independent. Tempus ECG-AF is a software solution integrated into healthcare facility systems and is compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems.
Sonix Health provides AI-powered fully-automated echocardiography analysis, including view recognition (37 FDA-approved views), auto measurement of B-mode, M-mode, Doppler parameters, and auto strain analysis (LV, LA, and RV Strain without EKG). Tempus ECG-AF detects signs associated with new onset Atrial Fibrillation (AF) within 12 months.
Sonix Health requires contacting the vendor for pricing, with no specific reimbursement information provided. Tempus ECG-AF has CMS reimbursement available (CPT 0764T and CPT 0765T to APC 5734, with a Medicare rate of $128.90, effective January 1, 2025).